Dis-Chem Pharmacies Limited (JSE: DCP)
South Africa
· Delayed Price · Currency is ZAR · Price in ZAc 3,450.00
+71.00 (2.10%)
Feb 4, 2025, 4:11 PM SAST
Dis-Chem Pharmacies Revenue
Dis-Chem Pharmacies had revenue of 19.56B ZAR in the half year ending August 31, 2024, with 19.81% growth. This brings the company's revenue in the last twelve months to 37.99B, up 11.11% year-over-year. In the fiscal year ending February 29, 2024, Dis-Chem Pharmacies had annual revenue of 36.28B with 11.08% growth.
Revenue (ttm)
37.99B
Revenue Growth
+11.11%
P/S Ratio
0.77
Revenue / Employee
1.90M
Employees
20,000
Market Cap
29.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 29, 2024 | 36.28B | 3.62B | 11.08% |
| Feb 28, 2023 | 32.66B | 2.26B | 7.42% |
| Feb 28, 2022 | 30.41B | 4.13B | 15.71% |
| Feb 28, 2021 | 26.28B | 2.29B | 9.56% |
| Feb 29, 2020 | 23.98B | 2.56B | 11.97% |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 28, 2018 | Pro | Pro | Pro |
| Feb 28, 2017 | Pro | Pro | Pro |
| Feb 29, 2016 | Pro | Pro | Pro |
| Feb 28, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Clicks Group | 45.44B |
| Aspen Pharmacare Holdings | 44.71B |
| Life Healthcare Group Holdings | 25.79B |
| Netcare | 25.20B |
| Adcock Ingram Holdings | 9.64B |
| AfroCentric Investment Corporation | 8.90B |
| Ascendis Health | 1.47B |
| RH Bophelo | 280.76M |
Dis-Chem Pharmacies News
- 3 months ago - Dis-Chem Pharmacies Ltd (JSE:DCP) Half Year 2025 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 3 months ago - Half Year 2025 Dis-Chem Pharmacies Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Dis-Chem versus Clicks - Daily Investor